Literature DB >> 2897789

Benzodiazepine withdrawal: overview and implications for the treatment of anxiety.

P P Roy-Byrne1, D Hommer.   

Abstract

The authors critically review 20 reports (studies and large case series) detailing the nature, severity, and variability of benzodiazepine withdrawal syndromes. Factors affecting the frequency and intensity of withdrawal are identified, and methodologic problems limiting the generalizability of certain findings are pointed out. Treatment approaches for minimizing withdrawal are reviewed, and implications for the problem of long-term benzodiazepine use and dependence are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2897789     DOI: 10.1016/0002-9343(88)90309-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  13 in total

1.  Lorazepam discontinuation promotes 'inverse agonist' effects of benzodiazepines.

Authors:  A Schatzki; F Lopez; D J Greenblatt; R I Shader; L G Miller
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Treatment of benzodiazepine withdrawal symptoms with carbamazepine.

Authors:  D Garcia-Borreguero; T Bronisch; S Apelt; A Yassouridis; H M Emrich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.

Authors:  Michael W Otto; R Kathryn McHugh; Naomi M Simon; Frank J Farach; John J Worthington; Mark H Pollack
Journal:  Behav Res Ther       Date:  2010-04-28

4.  Medical and psychosocial factors predictive of psychotropic drug use in elderly patients.

Authors:  L D Ried; D B Christensen; A Stergachis
Journal:  Am J Public Health       Date:  1990-11       Impact factor: 9.308

5.  Neuropharmacology of a new potential anxiolytic compound, F 2692, 1-(3'-trifluoromethyl phenyl) 1,4-dihydro 3-amino 4-oxo 6-methyl pyridazine. 1. Acute and in vitro effects.

Authors:  M B Assié; P Chopin; A Stenger; C Palmier; M Briley
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  Benzodiazepine prescribing patterns in a high-prescribing Scandinavian community.

Authors:  A Ekedahl; J Lidbeck; T Lithman; D Noreen; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

7.  Diazepam dependence prevented by glutamate antagonists.

Authors:  K G Steppuhn; L Turski
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation.

Authors:  Antonio Veronese; Massimo Garatti; Andrea Cipriani; Corrado Barbui
Journal:  Eur J Clin Pharmacol       Date:  2007-07-10       Impact factor: 2.953

Review 9.  Theoretical and therapeutic considerations for the anxiety disorders.

Authors:  L Taylor; J Gorman
Journal:  Psychiatr Q       Date:  1992

10.  Increased sensitivity to benzodiazepine antagonists in rats following chronic treatment with a low dose of diazepam.

Authors:  I Lucki; R F Kucharik
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.